COVID 19 Special Collection
COVID-19 (SARS-CoV-2) Special Collection
Latest COVID-19 Articles
-
Research Article
EMPress Enables Tree-Guided, Interactive, and Exploratory Analyses of Multi-omic Data Sets
Phylogenetic trees are integral data structures for the analysis of microbial communities. Recent work has also shown the utility of trees constructed from certain metabolomic data sets, further highlighting their importance in microbiome research. The ever-growing scale of modern microbiome surveys has led to numerous challenges in visualizing these data. In this paper we used five diverse data sets to showcase the versatility and scalability of EMPress, an interactive web visualization tool. EMPress addresses the growing need for exploratory analysis tools that can accommodate large, complex multi-omic data sets.
Kalen Cantrell, Marcus W. Fedarko, Gibraan Rahman, Daniel McDonald, Yimeng Yang, Thant Zaw, Antonio Gonzalez, Stefan Janssen, Mehrbod Estaki, Niina Haiminen, Kristen L. Beck, Qiyun Zhu, Erfan Sayyari, James T. Morton, George Armstrong, Anupriya Tripathi, Julia M. Gauglitz, Clarisse Marotz, Nathaniel L. Matteson, Cameron Martino, Jon G. Sanders, Anna Paola Carrieri, Se Jin Song, Austin D. Swafford, Pieter C. Dorrestein, Kristian G. Andersen, Laxmi Parida, Ho-Cheol Kim, Yoshiki Vázquez-Baeza, Rob Knight
16 March 2021, mSystems
-
Genome Sequences
Coding-Complete Genome Sequence and Phylogenetic Relatedness of a SARS-CoV-2 Strain Detected in March 2020 in Cameroon
We describe the coding-complete genome sequence of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain obtained in Cameroon from a 58-year-old French patient who arrived from France on 24 February 2020. Phylogenetic analysis showed that this virus, named hCoV-19/Cameroon/1958-CMR-YAO/2020, belongs to lineage B.1.5 and is closely related to an isolate from France.
Richard Njouom, Serge Alain Sadeuh-Mba, Jules Tchatchueng, Moussa Moïse Diagne, Ndongo Dia, Paul Alain Ngoupo Tagnouokam, Yap Boum, Achta Hamadou, Linda Esso, Ousmane Faye, Mathurin Cyrille Tejiokem, Marie Claire Okomo, Alain Etoundi, Elisabeth Carniel, Sara Eyangoh
11 March 2021, MRA
-
Genome Sequences
Coding-Complete Genome Sequences and Mutation Profiles of Nine SARS-CoV-2 Strains Detected from COVID-19 Patients in Bangladesh
Here, we report the coding-complete genome sequences of nine clinical severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants and their mutations. The samples were collected from nine Bangladeshi coronavirus disease 2019 (COVID-19) patients. We have identified the E484K escape mutation and the S359T mutation within the spike protein coding region of the sequenced genomes.
Nihad Adnan, Mohib Ullah Khondoker, M. Shaminur Rahman, M. Firoz Ahmed, Shahana Sharmin, Nadim Sharif, Nafisa Azmuda, Salma Akter, Shamsun Nahar, Taslin Jahan Mou, Mahfuza Marzan, Syeda Moriam Liza, Nowshin Jahan, Tamanna Ali, Shahad Saif Khandker, Maha Jamiruddin, Mousumi Akter Chaity, Laura Grace Caller, M. Ahsanul Haq, Mohd Raeed Jamiruddin
11 March 2021, MRA
-
Research Article
Susceptibility of white-tailed deer (Odocoileus virginianus) to SARS-CoV-2
Given the presumed zoonotic origin of SARS-CoV-2, the human-animal-environment interface of COVID-19 pandemic is an area of great scientific and public- and animal-health interest. Identification of animal species that are susceptible to infection by SARS-CoV-2 may help to elucidate the potential origin of the virus, identify potential reservoirs or intermediate hosts, and define the mechanisms underlying cross-species transmission to humans. Additionally, it may also provide information and help to prevent potential reverse zoonosis that could lead to the establishment of a new wildlife hosts. Our data show that upon intranasal inoculation, white-tailed deer became subclinically infected and shed infectious SARS-CoV-2 in nasal secretions and feces. Importantly, indirect contact animals were infected and shed infectious virus, indicating efficient SARS-CoV-2 transmission from inoculated animals. These findings support the inclusion of wild cervid species in investigations conducted to assess potential reservoirs or sources of SARS-CoV-2 of infection.
Mitchell V. Palmer, Mathias Martins, Shollie Falkenberg, Alexandra Buckley, Leonardo C. Caserta, Patrick K. Mitchell, Eric D. Cassmann, Alicia Rollins, Nancy C. Zylich, Randall W. Renshaw, Cassandra Guarino, Bettina Wagner, Kelly Lager, Diego G. Diel
Accepted Manuscript Posted 10 March 2021, JVI
-
Research Article
Coronavirus-Specific Antibody Cross Reactivity in Rhesus Macaques Following SARS-CoV-2 Vaccination and Infection
The rapid development and deployment of SARS-CoV-2 vaccines has been unprecedented. In this study, we explore the cross-reactivity of SARS-CoV-2 specific antibody responses to other coronaviruses. By analyzing responses from NHPs both before and after immunization with DNA or Ad26 vectored vaccines, we find patterns of cross reactivity that mirror those induced by SARS-CoV-2 infection. These data highlight the similarities between infection and vaccine induced humoral immunity for SARS-CoV-2 and cross-reactivity of these responses to other CoVs.
Catherine Jacob-Dolan, Jared Feldman, Katherine McMahan, Jingyou Yu, Roland Zahn, Frank Wegmann, Hanneke Schuitemaker, Aaron G. Schmidt, Dan H. Barouch
Accepted Manuscript Posted 10 March 2021, JVI
-
Research Article
Cryo-EM structure of S-Trimer, a subunit vaccine candidate for COVID-19
Effective vaccine against SARS-CoV-2 is critical to end the COVID-19 pandemic. Here, using Trimer-Tag technology, we are able to produce stable and large quantities of WT S-Trimer, a subunit vaccine candidate for COVID-19 with high safety and efficacy from animal and Phase 1 clinical trial studies. Cryo-EM structures of the S-Trimer subunit vaccine candidate show that it predominately adopts tightly closed pre-fusion state, and resembles that of the native and full-length spike in detergent, confirming its structural integrity. WT S-Trimer is currently being evaluated in global Phase 2/3 clinical trial. Combining with published structures of the S protein, we also propose a model to dissect the conformation change of the spike protein before receptor binding.
Jiahao Ma, Danmei Su, Yinyan Sun, Xueqin Huang, Ying Liang, Linqiang Fang, Yan Ma, Wenhui Li, Peng Liang, Sanduo Zheng
Accepted Manuscript Posted 10 March 2021, JVI
-
Research Article
SARS-CoV-2 rapidly adapts in aged BALB/c mice and induces typical pneumonia
Aged BALB/c model are in use as a model of disease caused by SARS-CoV-2. Our research demonstrated SARS-CoV-2 can rapidly adapt in aged BALB/c mice through causing mutations at the RBD of the S protein. Moreover, SARS-CoV-2-infected aged BALB/c mice indicated that alveolar damage, interstitial pneumonia, and inflammatory immune responses were similar to the clinical manifestations of human infections. Therefore, our aged BALB/c challenge model will be useful for further understanding the pathogenesis of SARS-CoV-2 and for testing vaccines and antiviral agents.
Yufei Zhang, Kun Huang, Ting Wang, Fei Deng, Wenxiao Gong, Xianfeng Hui, Ya Zhao, Xinlin He, Chengfei Li, Qiang Zhang, Xi Chen, Changjie Lv, Xian Lin, Ying Yang, Xiaomei Sun, Zhengli Shi, Huanchun Chen, Zhong Zou, Meilin Jin
Accepted Manuscript Posted 10 March 2021, JVI
-
Opinion/Hypothesis
Original Antigenic Sin: the Downside of Immunological Memory and Implications for COVID-19
The concept of original antigenic sin (OAS) was put forth many years ago to explain how humoral memory responses generated against one set of antigens can affect the nature of antibody responses elicited to challenge infections or vaccinations containing a similar but not identical array of antigens. Here, we highlight the link between OAS and the germinal center reaction (GCR), a process unique to activated B cells undergoing somatic hypermutation and class switch recombination. It is the powerful response of activated memory B cells and the accompanying GCR that establish the foundations of OAS. We apply these concepts to the current COVID-19 pandemic and put forth several possible scenarios whereby OAS may result in either beneficial or harmful outcomes depending, hypothetically, on prior exposure to antigens shared between SARS-CoV-2 and seasonal human coronaviruses (hCoVs) that include betacoronaviruses (e.g., HCoV-OC43 and HCoV-HKU1) and alphacoronaviruses (e.g., HCoV-NL63 and HCoV-HKU1) (E. M. Anderson, E. C. Goodwin, A. Verma, C. P. Arevalo, et al., medRxiv, 2020, https://doi.org/10.1101/2020.11.06.20227215; S. M. Kissler, C. Tedijanto, E. Goldstein, Y. H. Grad, and M. Lipsitch, Science 368:860–868, 2020, https://doi.org/10.1126/science.abb5793).
Eric L. Brown, Heather T. Essigmann
10 March 2021, mSphere
-
Research Article
The PRRA insert at the S1/S2 site modulates cellular tropism of SARS-CoV-2 and ACE2 usage by the closely related Bat RaTG13
The four-residue insert (PRRA) at the boundary between the S1and S2 subunits of SARS-CoV-2 has been widely recognized since day 1 for its role in SARS-CoV-2 S protein processing and activation. As this PRRA insert is unique to SARS-CoV-2 among group b betacoronaviruses, it is thought to affect the tissue and species tropism of SARS-CoV-2. We compared the usage of 10 ACE2 orthologs and found that the presence of PRRA not only affects the cellular tropism of SARS-CoV-2 but also modulates the usage of ACE2 orthologs by the closely related bat RaTG13 S protein. The binding of pseudovirions carrying RaTG13 S with a PRRA insert to mouse ACE2 was nearly 2-fold higher than that of pseudovirions carrying RaTG13 S.
Shufeng Liu, Prabhuanand Selvaraj, Christopher Z. Lien, Ivette A. Nunez, Wells W. Wu, Chao-Kai Chou, Tony T. Wang
Accepted Manuscript Posted 8 March 2021, JVI
-
Research Article
Evaluation of specimen types and saliva stabilization solutions for SARS-CoV-2 testing
Identifying SARS-CoV-2 infections through aggressive diagnostic testing remains critical in tracking and curbing the spread of the COVID-19 pandemic. Collection of nasopharyngeal swabs (NPS), the preferred sample type for SARS-CoV-2 detection, has become difficult due to the dramatic increase in testing and consequential supply strain. Therefore, alternative specimen types have been investigated, that provide similar detection sensitivity with reduced health care exposure and potential for self-collection. In this study, the detection sensitivity of SARS-CoV-2 in nasal swabs (NS) and saliva was compared to that of NPS, using matched specimens from two outpatient cohorts in New York State (total n = 463). The first cohort showed only a 5.4% positivity but the second cohort (n=227) had a positivity rate of 41%, with sensitivity in NPS, NS and saliva of 97.9%, 87.1%, and 87.1%, respectively. Whether the reduced sensitivity of NS or saliva is acceptable must be assessed in the settings where they are used. However, we sought to improve on it by validating a method to mix the two sample types, as the combination of nasal swab and saliva resulted in 94.6% SARS-CoV-2 detection sensitivity. Spiking experiments showed that combining them did not adversely affect the detection sensitivity in either. Virus stability in saliva was also investigated, with and without the addition of commercially available stabilizing solutions. The virus was stable in saliva at both 4°C and room temperature for up to 7 days. The addition of stabilizing solutions did not enhance stability and in some situations reduced detectable virus levels.
Sara B Griesemer, Greta Van Slyke, Dylan Ehrbar, Klemen Strle, Tugba Yildirim, Dominick A Centurioni, Anne C Walsh, Andrew K. Chang, Michael J Waxman, Kirsten St. George
Accepted Manuscript Posted 5 March 2021, JCM
-
Research Article
Portable RT-PCR system: A Rapid and Scalable Diagnostic Tool for COVID-19 Testing
Combating the ongoing coronavirus disease 2019 (COVID-19) pandemic demands accurate, rapid, and point-of-care testing with fast results to triage cases for isolation and treatment. The current testing relies on RT-PCR, which is routinely performed in well-equipped laboratories by trained professionals at specific locations. However, during busy periods high numbers of samples queued for testing can delay the test results, impacting upon efforts to reduce the infection risk. Besides, the absence of well-established laboratories at remote sites and low-resourced environments can contribute to a silent spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). These reasons compel the need to accommodate point-of-care testing for COVID-19 that meets the ASSURED criteria (Affordable, Sensitive, Specific, User-friendly, Rapid, robust, Equipment-free, and Deliverable). This study assessed the agreement and accuracy of the portable Biomeme SARS-CoV-2 system against the gold standard tests. Nasopharyngeal and nasal swabs were used. Of the 192 samples tested using the Biomeme SARS-CoV-2 system, the results from 189 samples (98.4%) were in agreement with the reference standard-of-care RT-PCR testing for SARS-CoV-2. The portable system generated simultaneous results for nine samples in 80 mins with high positive and negative percent agreements of 99.0% and 97.8%, respectively. We performed separate testing in a sealed glove box, offering complete biosafety containment. Thus, the Biomeme SARS-CoV-2 system can help decentralize COVID-19 testing and offer rapid test results for patients in remote and low-resourced settings.
Hosam M Zowawi, Thamer H Alenazi, Waleed S AlOmaim, Ahmad Wazzan, Abdullah Alsufayan, Rihab A Hasanain, Omar S Aldibasi, Sahar Althawadi, Sarah A Altamimi, Maysoon Mutabagani, Maha Alamri, Reem S Almaghrabi, Hail M Al-Abdely, Ziad A Memish, Saleh A Alqahtani
Accepted Manuscript Posted 4 March 2021, JCM
-
Genome Sequences
Identification of a SARS-CoV-2 Lineage B1.1.7 Virus in New York following Return Travel from the United Kingdom
Here, we report the identification and coding-complete genome sequence of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain (NYI.B1-7.01-21) obtained from a patient with symptoms of COVID-19 who had a recent travel history to the United Kingdom. The sample was tested by the Cayuga Health Systems laboratory as part of New York State’s travel testing guidance and was sequenced at Cornell University after testing positive.
Leonardo C. Caserta, Patrick K. Mitchell, Elizabeth Plocharczyk, Diego G. Diel
4 March 2021, MRA
-
Research Article
Potent Neutralization of SARS-CoV-2 by Hetero-bivalent Alpaca Nanobodies Targeting the Spike Receptor-Binding Domain
To date, SARS-CoV-2 has caused tremendous loss of human life and economic output worldwide. Although a few COVID-19 vaccines have been approved in several countries, the development of effective therapeutics, including SARS-CoV-2 targeting antibodies, remains critical. Due to their small size (13-15 kDa), high solubility, and stability, Nbs are particularly well suited for pulmonary delivery and more amenable to engineer into multivalent formats than the conventional antibody. Here, we report a series of new anti-SARS-CoV-2 Nbs isolated from immunized alpaca and two engineered hetero-bivalent Nbs. These potent neutralizing Nbs showed promise as potential therapeutics against COVID-19.
Huan Ma, Weihong Zeng, Xiangzhi Meng, Xiaoxue Huang, Yunru Yang, Dan Zhao, Peigen Zhou, Xiaofang Wang, Changcheng Zhao, Yong Sun, Peihui Wang, Huichao Ou, Xiaowen Hu, Yan Xiang, Tengchuan Jin
Accepted Manuscript Posted 3 March 2021, JVI
-
Research Article
Evaluating the Antimicrobial Properties of Commercial Hand Sanitizers
In response to the coronavirus disease 2019 (COVID-19) pandemic, hand hygiene has taken on a prominent role in efforts to mitigate SARS-CoV-2 transmission and infection, which has led to a radical increase in the number and types of hand sanitizers manufactured to meet public demand. To our knowledge, no studies have evaluated or compared the antimicrobial performance of hand sanitizers that are being produced under COVID-19 emergency authorization. Tests of 46 commercially available hand sanitizers purchased from national chain brick-and-mortar stores revealed considerable variability in their antibacterial performance toward two bacterial pathogens of immediate health care concern, S. aureus and E. coli. Expanded testing of a subset of hand sanitizers revealed no direct correlation between antibacterial performance of individual sanitizers and their activity toward SARS-CoV-2. These results indicate that as the pandemic subsides, there will be a need to validate the antimicrobial efficacy of sanitizers being produced.
M. Chojnacki, C. Dobrotka, R. Osborn, W. Johnson, M. Young, B. Meyer, E. Laskey, R. A. F. Wozniak, S. Dewhurst, P. M. Dunman
3 March 2021, mSphere
-
Research Article
Rapid High Throughput Whole Genome Sequencing of SARS-CoV-2 by using One-step RT-PCR Amplification with Integrated Microfluidic System and Next-Gen Sequencing
The long-lasting global COVID-19 pandemic demands timely genomic investigation of SARS-CoV-2 viruses. Here we report a simple and efficient workflow for whole genome sequencing utilizing one-step RT-PCR amplification on a microfluidic platform, followed by MiSeq amplicon sequencing. The method uses Fluidigm Integrated Fluidic Circuit (IFC) and instruments to amplify 48 samples with 39 pairs of primers, including 35 custom designed primer pairs and four additional primer pairs from the ARTIC network protocol v3. Application of this method on RNA samples from both viral isolate and clinical specimens demonstrate robustness and efficiency of this method in obtaining the full genome sequence of SARS-CoV-2.
Tao Li, Hye Kyung Chung, Papa K. Pireku, Brett F. Beitzel, Mark A. Sanborn, Cynthia Y. Tang, Richard Hammer, Detlef Ritter, XiuFeng Wan, Irina Maljkovic Berry, Jun Hang
Accepted Manuscript Posted 2 March 2021, JCM
Podcast from AAC
Vaccines for COVID19: A Critical Appraisal with Dr. Carol Baker. Guest: Dr. Carol Baker. Hosted by AAC Editor in Chief Cesar A. Arias.
Podcast from JCM
Watch COVID-19: Clinical Labs in the Media Spotlight with Dr. Katherine Wu and Dr. Susan Butler-Wu. Hosted by Journal of Clinical Microbiology Editor in Chief Dr. Alexander McAdam.
Podcast from mSystems
Watch Pandemic Built Environment with Dr. Leslie Dietz, Dr. Patrick Horve, and Dr. Kevin Van Den Wymelenberg. Hosted by mSystems Editor in Chief Dr. Jack A. Gilbert.